A pharmaceutical composition comprising the compound 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazo- le, or a pharmaceutically acceptable salt or solvate thereof, in an amorphous form.